& Artandi, S
After a surprise contest with Novo Nordisk in October over its plans to acquire Metsera, the pharmaceutical giant won out in November to seal the deal for the biopharma company
What to tell your rheumatologist If you are considering tirzepatide, bring this topic to your rheumatologist first
However, the emergence of modern obesity management medicines (OMMs), especially GLP-1 receptor agonists and dual incretin therapies such as semaglutide and tirzepatide, has dramatically changed the obesity treatment landscape
These values represent reference reconstitution math reported in research settings and are shared strictly for research-use-only purposes, not medical advice
Dhanapalaratnam R, Issar T, Lee ATK, Poynten AM, Milner KL, Kwai NCG, et al